Market Cap 71.02M
Revenue (ttm) 41.81M
Net Income (ttm) 6.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 15.91%
Debt to Equity Ratio 0.00
Volume 93,900
Avg Vol 115,604
Day's Range N/A - N/A
Shares Out 16.44M
Stochastic %K 74%
Beta 1.38
Analysts Strong Sell
Price Target $7.00

Company Profile

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as oth...

Industry: Medical Devices
Sector: Healthcare
Phone: 561 922 5808
Fax: 561 948 2071
Address:
851 Broken Sound Parkway NW, Suite 215, Boca Raton, United States
perfectson
perfectson Nov. 12 at 6:21 PM
$SRTS small is an understatement , spent $4000
2 · Reply
BigPimpin126
BigPimpin126 Nov. 12 at 5:03 PM
$SRTS keep this rocket going
0 · Reply
Stradella
Stradella Nov. 12 at 4:25 PM
$SRTS Sardano Form 4, small purchase https://s3.amazonaws.com/sec.irpass.cc/2796/0001720602-25-000004.htm
0 · Reply
Stradella
Stradella Nov. 12 at 4:24 PM
$SRTS https://sensushealthcare.com/sensus-healthcare-appoints-eric-sachetta-to-its-board-of-directors/
0 · Reply
kubota2323
kubota2323 Nov. 12 at 4:02 PM
$SRTS added.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 10:05 PM
$STBA $ST $SSP $SSL $SRTS 11/07 11/21
0 · Reply
BioTechHealthX
BioTechHealthX Nov. 9 at 7:41 AM
$SRTS Sensus Healthcare combines cash strength, nascent recurring-revenue model and scalable skin-cancer device platform. Click here for more info! https://biotechhealthx.com/biotech-news/why-sensus-healthcare-srts-could-be-a-hidden-med-tech-gem-in-2026/
1 · Reply
Bravosatya
Bravosatya Nov. 9 at 12:00 AM
$SRTS shared details thoughts on my X account. Please follow me on X if you like the article I posted https://x.com/bravosatya/status/1987308323285156160?s=46&t=K-mrSWrpS0MBpymbXzaYcg
1 · Reply
makikula
makikula Nov. 8 at 7:23 AM
$SRTS My average is 3.5 USD on this, waiting for it to crosss 5usd
0 · Reply
stklover
stklover Nov. 8 at 1:22 AM
$SRTS I’ve been burned on this name a few years ago.
0 · Reply
Latest News on SRTS
Sensus Healthcare Announces the Passing of Director Bill McCall

Oct 31, 2025, 8:00 AM EDT - 17 days ago

Sensus Healthcare Announces the Passing of Director Bill McCall


Sensus Healthcare, Inc. (SRTS) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 2:43 PM EDT - 3 months ago

Sensus Healthcare, Inc. (SRTS) Q2 2025 Earnings Call Transcript


Sensus Healthcare Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 3 months ago

Sensus Healthcare Reports Second Quarter 2025 Financial Results


Sensus Healthcare, Inc. (SRTS) Q1 2025 Earnings Call Transcript

May 15, 2025, 7:58 PM EDT - 6 months ago

Sensus Healthcare, Inc. (SRTS) Q1 2025 Earnings Call Transcript


Sensus Healthcare Reports First Quarter 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 6 months ago

Sensus Healthcare Reports First Quarter 2025 Financial Results


Sensus Healthcare Buys Back Shares

Feb 11, 2025, 8:00 AM EST - 9 months ago

Sensus Healthcare Buys Back Shares


Sensus Healthcare: A Tough Q1 2025 Awaits Ahead

Feb 7, 2025, 9:04 AM EST - 10 months ago

Sensus Healthcare: A Tough Q1 2025 Awaits Ahead


Sensus Healthcare, Inc. (SRTS) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 10:22 PM EST - 10 months ago

Sensus Healthcare, Inc. (SRTS) Q4 2024 Earnings Call Transcript


Sensus Healthcare to Present at The Microcap Conference 2025

Jan 23, 2025, 8:00 AM EST - 10 months ago

Sensus Healthcare to Present at The Microcap Conference 2025


Sensus Healthcare: Recurring Revenue Initiatives Are Exciting

Aug 25, 2024, 11:03 AM EDT - 1 year ago

Sensus Healthcare: Recurring Revenue Initiatives Are Exciting


Sensus Healthcare, Inc. (SRTS) Q1 2024 Earnings Call Transcript

May 11, 2024, 11:32 AM EDT - 1 year ago

Sensus Healthcare, Inc. (SRTS) Q1 2024 Earnings Call Transcript


perfectson
perfectson Nov. 12 at 6:21 PM
$SRTS small is an understatement , spent $4000
2 · Reply
BigPimpin126
BigPimpin126 Nov. 12 at 5:03 PM
$SRTS keep this rocket going
0 · Reply
Stradella
Stradella Nov. 12 at 4:25 PM
$SRTS Sardano Form 4, small purchase https://s3.amazonaws.com/sec.irpass.cc/2796/0001720602-25-000004.htm
0 · Reply
Stradella
Stradella Nov. 12 at 4:24 PM
$SRTS https://sensushealthcare.com/sensus-healthcare-appoints-eric-sachetta-to-its-board-of-directors/
0 · Reply
kubota2323
kubota2323 Nov. 12 at 4:02 PM
$SRTS added.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 11 at 10:05 PM
$STBA $ST $SSP $SSL $SRTS 11/07 11/21
0 · Reply
BioTechHealthX
BioTechHealthX Nov. 9 at 7:41 AM
$SRTS Sensus Healthcare combines cash strength, nascent recurring-revenue model and scalable skin-cancer device platform. Click here for more info! https://biotechhealthx.com/biotech-news/why-sensus-healthcare-srts-could-be-a-hidden-med-tech-gem-in-2026/
1 · Reply
Bravosatya
Bravosatya Nov. 9 at 12:00 AM
$SRTS shared details thoughts on my X account. Please follow me on X if you like the article I posted https://x.com/bravosatya/status/1987308323285156160?s=46&t=K-mrSWrpS0MBpymbXzaYcg
1 · Reply
makikula
makikula Nov. 8 at 7:23 AM
$SRTS My average is 3.5 USD on this, waiting for it to crosss 5usd
0 · Reply
stklover
stklover Nov. 8 at 1:22 AM
$SRTS I’ve been burned on this name a few years ago.
0 · Reply
BigPimpin126
BigPimpin126 Nov. 7 at 8:11 PM
$SRTS regulations that actually HELP here strengthens this company even more. Great things to come
0 · Reply
Bravosatya
Bravosatya Nov. 7 at 5:54 PM
$SRTS Are you accumulating this multi bagger? I am cautiously optimistic! What are your thoughts?
0 · Reply
Bravosatya
Bravosatya Nov. 6 at 10:57 PM
$SRTS 7 and Last node I took is International revenue expectations- I think it was Michael- I think that we'll get to consistently about a 20% revenue base international, which will be 20% of our total revenue. Right now. We're somewhere between 5 and 10%. I think we can grow that over the next 12 to 24 months to about 20%. And if I may add the the vision, don't forget, is actually taking off internationally as well. Taiwan has two visions now, and there is some demand in Asia for the SRT 100 vision. And we plan to submit for regulatory clearance to China for the vision as well, which we had not had in the past. So the vision might start becoming a very big international unit for us, much like the SRT 100 was for the last 6 or 7 years.
1 · Reply
Bravosatya
Bravosatya Nov. 6 at 10:54 PM
$SRTS 6. Impact of new code Joe explains contd- But either way, you're going to see our margins now starting to take shape. And I see the longevity of the product and the utilization of it as as reimbursement stabilizes and it becomes fact. Imagine this in the past, doctors used coding and they asked for reimbursement. Sometimes they would get it, sometimes they wouldn't. Now there's no way that anybody can refuse these codes. These reimbursements, because it's what CMS says. They said this exists for SRT technology, for the dermatology space to treat skin cancer and keloids. So there undeniable. And so if you look at the amount of money that they're going to be getting on a patient by patient basis, I mean it is a very, very strong reimbursement for them. That bodes well for the ROI on the equipment, whether it's taken in the FDA form or whether they purchase it through a lease or direct purchase either way. So it's beneficial for the company.
0 · Reply
Bravosatya
Bravosatya Nov. 6 at 10:50 PM
$SRTS Impact of new code Joe explains- I don't think that our FDA is as impacted by the new coding as much as people think. And the makeup for whatever impact the ultrasound may have had is going to be taken up by the increase in the actual fractionation code of 340%. As Michael said. So it almost offsets any of the decreases. So I don't think that it's going to impact our FDA program that much. And I think that we'll be able to continue with that. FDA program. So I think that that's very viable. I think the impact that it will have is that it will increase sales on the SRT 100 side, because that's the lower cost unit.
0 · Reply
Bravosatya
Bravosatya Nov. 6 at 10:46 PM
$SRTS 4 . LCD issue - Additionally, I want to point out, Ben two, that the LCD, when it first came out and then following that, the CMS proposed physician fee schedule. Now, the final, they kind of contradicted each other. And now CMS has put that issue to bed. So they actually did give the ultrasound for the first time its own code. There is an ultrasound code for SRT in association with SRT, which means they believe it is clinically viable and important.
0 · Reply
Bravosatya
Bravosatya Nov. 6 at 10:42 PM
$SRTS 3. Credibility - And with that pent up demand, if I may add, we bought a lot of credibility. I'm really proud of our sales team, sales force nationally for going to this and actually, from a short term perspective, holding off on receiving some money in Q2, Q3, we could have easily gone out and just, you know, not told everyone and sold in all these units. But we bought credibility with the practices, with the large roll up groups and told them, you know what, let's figure out exactly what's going to come down. And now I think you're going to see that that's going to work out for us. Okay, great. Thank you.
0 · Reply
Bravosatya
Bravosatya Nov. 6 at 10:41 PM
$SRTS 2 . Demand & Qtr-4 expectations- We announced the last quarter that when the LCD came out that there was a complete stop to the order taking, and halted. We feel now that we have clarity that we'll be able to deliver those units so that we can start production with those customers. And with guaranteed reimbursement codes that begin January 1st, I think we're going to have customers that get in line to purchase and or to implement the program this year. And of course, it's going to be first come, first serve. I think with the pent up demand, there's going to be some aggressive marketing. Demand for our products. And we don't know where that could be yet. But we think that we are going to either hit break even or be profitable for the fourth quarter.
0 · Reply
Bravosatya
Bravosatya Nov. 6 at 10:24 PM
$SRTS Earnings Call QA for those who missed Michael - I differentiated between SRT and IGSRT. Right. One has the image guidance. One doesn't. What this has done the 300% increase that Joe and I have talked about is the new delivery code, which basically CMS allowed the hospital rate in for the first time. Why was it for so long that if you were in a hospital setting, you'd get $125 per fraction, whereas the dermatologist would only get $25 per fraction. Well, now that is completely aligned. The new coding going up about 340%. We just said over 300% to make it make it sound easy in the script. So the base SRT 100 unit, which has been significantly less reimbursement overall than the as of late Igst unit vision, is now getting a 300 plus percent increase as well. And the vision does as well. So both products on the delivery code standpoint get a massive, massive increase, one that we've never seen before. In my days in healthcare, 15 years. Does that make sense?
0 · Reply
Bravosatya
Bravosatya Nov. 6 at 10:03 PM
$SRTS Michael just said LCD was “rubbish” and “baseless”
0 · Reply
newfguy
newfguy Nov. 6 at 9:36 PM
$SRTS good quarter!
0 · Reply
Bravosatya
Bravosatya Nov. 6 at 9:11 PM
$SRTS Sensus Healthcare Reports Third Quarter 2025 Financial Results - Sensus Healthcare https://sensushealthcare.com/sensus-healthcare-reports-third-quarter-2025-financial-results/
0 · Reply